Table 1.

Adipocyte size distribution in control and doxepin-treated obese mice over 56 treatment days.

Variable	Control	Doxepin
RWAT
Adipocyte diameter
0–50 μm (%)	20.00 ± 0.65	0 ± 0 ***
50–100 μm (%)	76.36 ± 1.25	10.91 ± 1.07 ***
100–150 μm (%)	3.64 ± 0.42	50.91 ± 1.12 ***
>150 μm (%)	0 ± 0	38.18 ± 0.96 ***
EWAT
Adipocyte diameter
0–50 μm (%)	5.45 ± 0.47	0 ± 0 ***
50–100 μm (%)	69.1 ± 0.94	12.73 ± 0.57 ***
100–150 μm (%)	25.45 ± 1.03	36.36 ± 1.69 ***
>150 μm (%)	0 ± 0	50.91 ± 1.42 ***

All values denote the mean ± standard deviation (n = 10 for all groups). *** p < 0.001 indicates very high statistical significance.